navbar brand navbar brand
  • Course Catalog
  • Event Calendar
  • Contact Us

You are being redirected to another site.


Back to Post List
New Post
Title(*)
Description
  • Introduction
Click on the on the top progress bar to review the step.
Journal CME 38.02: Diagnosis and Outcomes of Late-Onset Wilson’s Disease: A National Registry-Based Study

Journal CME 38.02

Course Format
Webinar
Release Date
February 16, 2023
Expiration Date
February 16, 2024
...
Program Description

The Journal CME 38.02 article provided a study to characterize the clinical and paraclinical presentations, therapeutic management, and outcomes in patients with late-onset Wilson's disease.

Course has been expired
Faculty

Christelle Nilles, MD - Department of Neurology, Rothschild Foundation Hospital, Paris, France, National Reference Center for Wilson’s Disease and Other Copper-Related Rare Diseases, Rothschild Foundation Hospital, Paris, France

Mickael Alexandre Obadia, MD - Department of Neurology, Rothschild Foundation Hospital, Paris, France, National Reference Center for Wilson’s Disease and Other Copper-Related Rare Diseases, Rothschild Foundation Hospital, Paris, France

Rodolphe Sobesky, MD, PhD - Centre Hépato-Biliaire, AP-HP, DHU Hepatinov, INSERM UMR-S 1193, Hôpital Paul Brousse, Villejuif, France

Jérôme Dumortier, MD, PhD - National Reference Center for Wilson’s Disease and Other Copper-Related Rare Diseases, Femme Mère Enfant Hospital, Hospices Civils de Lyon, Bron, France, Department of Hepatologie-Gastroenterologie, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France

Olivier Guillaud, MD - National Reference Center for Wilson’s Disease and Other Copper-Related Rare Diseases, Femme Mère Enfant Hospital, Hospices Civils de Lyon, Bron, France, Service d’explorations fonctionnelles digestives, CHU Lyon, Lyon, France

Chloé Laurencin, MD - National Reference Center for Wilson’s Disease and Other Copper-Related Rare Diseases, Femme Mère Enfant Hospital, Hospices Civils de Lyon, Bron, France, Service de Neurologie HFME—GHE, Bron Cedex, France

Caroline Moreau, MD, PhD - Service de neurologie et pathologies du mouvement, INSERM UMR, CHU Lille, Lille, France

Claire Vanlemmens, MD - Service d’Hépatologie et soins intensifs digestifs, CHU Besançon, Hôpital Jean Minjoz, Besançon, France

Fabienne Ory-Magne, MD - Service de Neurologie, Neurology Department, CHU Toulouse, Hôpital Purpan, Toulouse, France

Victor de Ledinghen, MD, PhD - Service d’Hépatologie-Gastroentérologie, Hôpital Haut-Lévêque, CHU Bordeaux, Pessac & INSERM U1312, Université de Bordeaux, Bordeaux, France

Edouard Bardou-Jacquet, MD, PhD - Service des maladies du foie, CHU Pontchaillou, Rennes Cedex 9, France

Frederique Fluchère, MD - Service de Neurologie, Neurology Department, CHU Marseille, Hôpital de la Timone, Marseille, France

Corinne Collet, MD, PhD - National Reference Center for Wilson’s Disease and Other Copper-Related Rare Diseases, Rothschild Foundation Hospital, Paris, France, Département de Génétique, Hôpital Robert Debré AP-HP, Paris, France

Nouzha Oussedik-Djebrani, MD - National Reference Center for Wilson’s Disease and Other Copper-Related Rare Diseases, Rothschild Foundation Hospital, Paris, France, Laboratoire de Toxicologie Biologique, Hôpital Lariboisière AP-HP, Paris, France

France Woimant, MD - National Reference Center for Wilson’s Disease and Other Copper-Related Rare Diseases, Rothschild Foundation Hospital, Paris, France

Aurélia Poujois, MD, PhD - Department of Neurology, Rothschild Foundation Hospital, Paris, France, National Reference Center for Wilson’s Disease and Other Copper-Related Rare Diseases, Rothschild Foundation Hospital, Paris, France

Course Purpose

Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.

Learning Objectives

Upon completion of this activity learners will be able to:

  1. Assess the need for data for a late-onset Wilson’s disease diagnosis.
  2. Understand the benefit of treatment personalization for patients with late-onset Wilson’s disease.
  3. Evaluate the clinical and paraclinical presentations, therapeutic management, and outcomes in patients with late-onset Wilson’s disease

Intended Audience

This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.

Method of Participation

Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed in the Accreditation Statement, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.

Faculty Disclosure

All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available below. All relevant financial relationships have been mitigated in advance of this program.


Sara Schaefer: Course Director

Nothing to Disclose


Veronica Santini: Reviewer

Grant: Insightec, Biogen, Roche / Genentech


Christelle Nilles: Author

Nothing to Disclose


Mickael Alexandre Obadia: Author

Nothing to Disclose


Rodolphe Sobesky: Author

Nothing to Disclose


Jérôme Dumortier: Author

Nothing to Disclose


Olivier Guillaud: Author

Nothing to Disclose


Chloé Laurencin: Author

Nothing to Disclose


Caroline Moreau: Author

Nothing to Disclose


Claire Vanlemmens: Author

Nothing to Disclose


Fabienne Ory-Magne: Author

Nothing to Disclose


Victor de Ledinghen: Author

Nothing to Disclose


Edouard Bardou-Jacquet: Author

Nothing to Disclose


Frederique Fluchère: Author

Nothing to Disclose


Corinne Collet: Author

Nothing to Disclose


Nouzha Oussedik-Djebrani: Author

Nothing to Disclose


France Woimant: Author

Nothing to Disclose


Aurélia Poujois: Author

Nothing to Disclose

Accreditation and Credit Designation

Accreditation Statement


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.


Credit Designation Statement


The International Parkinson and Movement Disorder Society designates this education activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Hardware and Software Requirement

1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.

2. Compatible with Windows PC and MAC (256 MB of RAM or higher)

3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher

4. Adobe Flash Player 12.0 (or higher).

5. Adobe Reader to print certificate.

Staff Disclosure

MDS staff members involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Disclaimer

All individuals in control of content for this course are required to disclose all relevant financial relationships with commercial interests as defined by the ACCME.

Contact Us
MDS Education
education@movementdisorders.org

Copyright © 1998-2025 International Parkinson and Movement Disorder Society (MDS). All Rights Reserved.

Processing...
×